A process for the preparation of a saturated aliphatic carboxylic acid with 3 to 5 carbon atoms by oxidation of the corresponding aldehyde with oxygen in which (a) the corresponding aldehyde is converted with oxygen at a temperature of 40 to 150° C. and an oxygen partial pressure of 0.001 to 1 MPa to obtain a mixture containing the saturated aliphatic carboxylic acid and ≤2 mol-% of the corresponding aldehyde with respect to the saturated aliphatic carboxylic acid, (b) the mixture obtained in step (a) is thermally treated in the liquid phase at a temperature of 80 to 250° C. and a pressure of 0.1 to 2 MPa abs for 0.25 to 100 hours, and (c) the mixture obtained in step (b) is distilled in a distillation apparatus to obtain a distillate containing ≥90 wt.-% of the saturated aliphatic carboxylic acid and having an active oxygen content of 0 to 25 wt.-ppm based on the distillate.

A process for the preparation of a saturated aliphatic carboxylic acid with 3 to 5 carbon atoms by oxidation of the corresponding aldehyde with oxygen in which (a) the corresponding aldehyde is converted with oxygen at a temperature of 40 to 150° C. and an oxygen partial pressure of 0.001 to 1 MPa to obtain a mixture containing the saturated aliphatic carboxylic acid and ≤2 mol-% of the corresponding aldehyde with respect to the saturated aliphatic carboxylic acid, (b) the mixture obtained in step (a) is thermally treated in the liquid phase at a temperature of 80 to 250° C. and a pressure of 0.1 to 2 MPa abs for 0.25 to 100 hours, and (c) the mixture obtained in step (b) is distilled in a distillation apparatus to obtain a distillate containing ≥90 wt.-% of the saturated aliphatic carboxylic acid and having an active oxygen content of 0 to 25 wt.-ppm based on the distillate.

The present invention relates to a process for synthesizing large scale a compound of formula (I), or pharmacuetically acceptable salt thereof, which is useful as the key intermediate for the synthesis of compounds for prophylaxis and treatment of a disease associated with the deposition of β-amyloid in the brain, in particular Alzheimer's disease, and other diseases such as cerebral amyloid angiopathy, hereditary cerebral hemorrhage with amyloidosis, Dutch-type (HCHWA-D), multi-infarct dementia, dementia pugilistica and Down syndrome.

##STR00001##

The present invention relates to a process for synthesizing large scale a compound of formula (I), or pharmacuetically acceptable salt thereof, which is useful as the key intermediate for the synthesis of compounds for prophylaxis and treatment of a disease associated with the deposition of β-amyloid in the brain, in particular Alzheimer's disease, and other diseases such as cerebral amyloid angiopathy, hereditary cerebral hemorrhage with amyloidosis, Dutch-type (HCHWA-D), multi-infarct dementia, dementia pugilistica and Down syndrome.

##STR00001##

The invention relates to methods of separating Trolox isomers (R)-Trolox and (S)-Trolox, comprising: (a) contacting a mixture of (R) and (S)-Trolox with a resolving agent selected from the group consisting of (1S,2S)-(+)-Pseudoephedrine, (R)-(+)-2-Amino-3-phenyl-1-propanol, (1R,2R)-(−)-Pseudoephedrine, and (S)-(−)-2-Amino-3-phenyl-1-propanol, wherein the resolving agent forms a solid salt with one of (R)-Trolox and (S)-Trolox, and substantially does not form a solid salt with the other; and (b) separating the solid salt from the Trolox isomer that did not form the solid salt with the resolving agent.

The invention relates to methods of separating Trolox isomers (R)-Trolox and (S)-Trolox, comprising: (a) contacting a mixture of (R) and (S)-Trolox with a resolving agent selected from the group consisting of (1S,2S)-(+)-Pseudoephedrine, (R)-(+)-2-Amino-3-phenyl-1-propanol, (1R,2R)-(−)-Pseudoephedrine, and (S)-(−)-2-Amino-3-phenyl-1-propanol, wherein the resolving agent forms a solid salt with one of (R)-Trolox and (S)-Trolox, and substantially does not form a solid salt with the other; and (b) separating the solid salt from the Trolox isomer that did not form the solid salt with the resolving agent.

Disclosed is a composition comprising dichloroacetic acid, a process for preparing the same and a use thereof. It has been discovered that the novel impurity is glyoxylic acid, and glyoxylic acid in dichloroacetic acid can be detected and its concentration accurately measured, by ion chromatography method.

Disclosed is a composition comprising dichloroacetic acid, a process for preparing the same and a use thereof. It has been discovered that the novel impurity is glyoxylic acid, and glyoxylic acid in dichloroacetic acid can be detected and its concentration accurately measured, by ion chromatography method.

Disclosed are a method for producing lactic acid from wastes containing cellulose and/or hemicellulose and a catalyst for thermochemical conversion reaction of wastes containing cellulose and/or hemicellulose. The method includes a step of adding a metal catalyst to wastes containing cellulose and/or hemicellulose and performing thermochemical conversion reaction. The method provides an effect of producing lactic acid from discarded wastes, e.g., waste paper such as waste corrugated paperboards, waste paper boxes, waste newspapers, etc.

Disclosed are a method for producing lactic acid from wastes containing cellulose and/or hemicellulose and a catalyst for thermochemical conversion reaction of wastes containing cellulose and/or hemicellulose. The method includes a step of adding a metal catalyst to wastes containing cellulose and/or hemicellulose and performing thermochemical conversion reaction. The method provides an effect of producing lactic acid from discarded wastes, e.g., waste paper such as waste corrugated paperboards, waste paper boxes, waste newspapers, etc.